Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR-1.5%
5Y CAGR+36.6%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-1.5%/yr
vs +70.2%/yr prior
5Y CAGR
+36.6%/yr
Recent deceleration
Acceleration
-71.7pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
4.8x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 102.81% |
| 2024 | -19.48% |
| 2023 | -55.38% |
| 2022 | 107.43% |
| 2021 | -43.58% |
| 2020 | 21.63% |
| 2019 | -5.19% |
| 2018 | 12.79% |
| 2017 | 255.24% |
| 2016 | -118910.42% |